Sio Capital Management, LLC Ventyx Biosciences, Inc. Call Options Transaction History
Sio Capital Management, LLC
- $268 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VTYX
# of Institutions
136Shares Held
60.3MCall Options Held
62.3KPut Options Held
127K-
Black Rock Inc. New York, NY4.77MShares$8.16 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.48MShares$7.66 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.27MShares$7.31 Million0.0% of portfolio
-
Ubs Group Ag3.78MShares$6.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$6 Million0.0% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $96.7M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...